Affinity Asset Advisors’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,989
Closed -$562K 84
2022
Q2
$562K Buy
13,989
+2,920
+26% +$213K 0.24% 46
2022
Q1
$1.18M Buy
11,069
+3,569
+48% +$559K 0.19% 46
2021
Q4
$1.87M Hold
7,500
0.68% 39
2021
Q3
$1.47M Hold
7,500
0.37% 50
2021
Q2
$1.5M Sell
7,500
-12,500
-63% -$2.54M 0.54% 42
2021
Q1
$4.06M Buy
20,000
+5,000
+33% +$1.09M 1.38% 17
2020
Q4
$3.2M Buy
+15,000
New +$3.12M 1.7% 18

Other funds holding SNCE

Affinity Asset Advisors's SNCE Position: Q3 2022 in Review

Affinity Asset Advisors sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 13,989 shares — an estimated $562K sold.

Affinity Asset Advisors first reported a position in SNCE in Q4 2020 and held it in 7 quarters. The position peaked at $4.06M in Q1 2021. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • Affinity Asset Advisors reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Affinity Asset Advisors sold 13,989 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $562K.
  • Affinity Asset Advisors first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Affinity Asset Advisors's Science 37 Holdings, Inc. Common Stock position peaked at $4.06M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Affinity Asset Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.